Inventiva SA (IVA)
3.45
+0.06
(+1.77%)
USD |
NASDAQ |
Nov 19, 16:00
3.42
-0.03
(-0.87%)
Pre-Market: 08:02
Inventiva Price to Book Value : 1.946 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.946 |
| November 18, 2026 | 1.912 |
| November 17, 2026 | 1.816 |
| November 16, 2026 | 1.873 |
| November 13, 2026 | 2.076 |
| November 12, 2026 | 2.189 |
| November 11, 2026 | 2.262 |
| November 10, 2026 | 2.228 |
| November 09, 2026 | 2.166 |
| November 06, 2026 | 2.144 |
| November 05, 2026 | 2.048 |
| November 04, 2026 | 2.183 |
| November 03, 2026 | 2.273 |
| November 02, 2026 | 2.160 |
| October 30, 2026 | 2.059 |
| October 29, 2026 | 2.104 |
| October 28, 2026 | 2.093 |
| October 27, 2026 | 2.079 |
| October 26, 2026 | 2.065 |
| October 23, 2026 | 2.093 |
| October 22, 2026 | 2.031 |
| October 21, 2026 | 2.002 |
| October 20, 2026 | 1.839 |
| October 19, 2026 | 1.681 |
| October 16, 2026 | 1.658 |
| Date | Value |
|---|---|
| October 15, 2026 | 1.754 |
| October 14, 2026 | 1.619 |
| October 13, 2026 | 1.619 |
| October 12, 2026 | 1.760 |
| October 09, 2026 | 1.782 |
| October 08, 2026 | 1.873 |
| October 07, 2026 | 1.898 |
| October 06, 2026 | 1.952 |
| October 05, 2026 | 1.963 |
| October 02, 2026 | 2.008 |
| October 01, 2026 | 1.952 |
| September 30, 2026 | 2.082 |
| September 29, 2026 | 1.856 |
| September 28, 2026 | 1.991 |
| September 25, 2026 | 1.901 |
| September 24, 2026 | 1.839 |
| September 23, 2026 | 1.946 |
| September 22, 2026 | 2.059 |
| September 21, 2026 | 2.059 |
| September 18, 2026 | 2.132 |
| September 17, 2026 | 2.115 |
| September 16, 2026 | 2.138 |
| September 15, 2026 | 2.177 |
| September 14, 2026 | 2.189 |
| September 11, 2026 | 2.268 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 3.984 |
| Cellectis SA | 2.412 |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Price to Book Value Related Metrics
| PS Ratio | 14078.05 |
| Price | 3.45 |
| Earnings Yield | -39.77% |
| Market Cap | 815.17M |